The Journal. · Monday, June 29, 2026
In response to rising GLP-1 costs, towns and states are exploring various strategies, including limiting coverage for weight loss specifically or covering only generic versions. Some are implementing monitoring systems for patient success to manage expenses.
“In many cases, they're retaining coverage, but just not for weight loss.”
“Some are saying, you know, maybe we'll cover this generic brand, but not this brand.”
“Um, some of them are saying, you know, we're going to cover this structure, kind of weight loss plan, but we're monitoring your success.”